The kidneys and antiphospholipid syndrome;Nerki a zespół antyfosfolipidowy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue SUPPL., 2007, Pages 55-58

  Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiphospholipid antibodies; Kidney involvement; Primary and secondary antiphospholipid syndrome

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; NEPHROTIC SYNDROME; RENOVASCULAR HYPERTENSION;

EID: 36549023411     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999; 42: 309-311.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4: 295-306.
3. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986; 13: 486-489.
4. Amigo MC. Kidney disease in antiphospholipid syndrome. Rheum Dis Clin North Am. 2006; 32: 509-522.
5. Uthman I, Khamashta M. Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum. 2006; 35: 360-367
6. Fakhouri F, Noël LH, Zuber J, et al. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis. 2003; 41: 1205-1211.
7. Nzerue CM, Hewan-Lowe K, Pierangeli S, et al. "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 2002; 62: 733-744.
8. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002; 46: 1019-1027.
9. Moss KE, Isenberg A. Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology. 2001; 40: 863-867.
10. Vlachoyiannopoulos PG, Kanellopoulos P, Tekonidou M, et al. Renal involvement in antiphospholipid sydrome. Nephrol Dial Transplant. 2001; 16 (Suppl 6): S60-S62.
11. Levine JS, Rauch J. Renal involvement in the anti-phospholipid syndrome. In: Adu D, Emery P, Madaio M, eds. Rheumatology and the kidney. Oxford, University Press, 2001: 132.
12. Cruz DP. Renal manifestations of the antiphospholipid syndrome. Lupus. 2005; 14: 45-48.
13. Daugas E, Nochy D, Huong DLT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Nephrol. 2002; 13: 42-52.
14. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998; 77: 195-207.
15. Bhowmik D, Dadhwal V, Dinda AK, et al. Steroid responsive focal segmental glomerulosclerosis in primary antiphospholipid syndrome with successful pregnancy outcome. Nephrol Dial Transplant. 2005; 20: 1726-1728.
16. Moroni G, Ventura D, Riva P, et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis. 2004; 43: 28-36.
17. Vaidya S. Management of end stage renal disease patients with antiphospholipid antibody syndrome. Transplant Proc. 2005; 37: 650-651.
18. Karim MY, Alba P, Tungekar MF, et al. Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus. 2002; 11: 253-256.
19. Dryglewska M, Suszek D, Przygoda-Dreher A, Majdan M. Anti- β2glycoprotein I antibodies as marker of activity of SLE. Annales UMCS, Sec. DDD. 2004; 17: 147-151.
20. Suszek D, Dryglewska M, Chudzik D, Majdan M. Lupus nephritis and antiphospholipid antibodies. Annales UMCS, Sec. D. 2005; 60: 263-268.
21. Suszek D, Majdan M, Chudzik D, Dryglewska M. Zależności miȩdzy nasileniem niedokrwistósci a obecnościa̧ wybranych przeciwciał antyfosfolipidowych u chorych na toczeń rumieniowaty. Pol Arch Med Wewn. 2006; 115: 426-432.
22. Majdan D, Suszek M, Dryglewska M. Relations between kidney damage in systemic lupus erythematosus and antiphospholipid antibodies. Ann Rheum Dis. 2006; 65: 203-204 [Abstract].
23. Majdan M, Wielosz E, Dryglewska M. Antiphospholipid antibodies in patients with systemic sclerosis. 43 Kongres ERA-EDTA, United Kingdom, Glasgow 2006. Nephrol Dial Transplant. 2006; 21 (Suppl 4): iv71 [Abstract].